Initial antibiotic susceptibility | Previous treatment regimen | Rescue treatment |
CLA and MET resistant or initial antimicrobial susceptibility unknown | Triple therapy |
|
Quadruple therapy (bismuth-based) |
| |
CLA and MET susceptible | PPI-AMO-CLA |
|
CLA and MET susceptible | PPI-AMO-MET |
|
CLA resistant, MET susceptible | PPI-AMO-MET |
|
CLA susceptible, MET resistant | PPI-AMO-CLA |
|
CLA: clarithromycin; MET: metronidazole; PPI: proton pump inhibitor; TET: tetracycline; AMO: amoxicillin.
* Consider substituting levofloxacin instead of MET if the patient had difficulty tolerating MET in the previous eradication attempt.
¶ Where bismuth is available, bismuth-based quadruple therapy is preferred due to better eradication rates compared with high-dose AMO. We use bismuth-based regimens when indicated. In the United States, bismuth is available only as bismuth subsalicylate, so we avoid it if the child has any flu-like illness because of theoretical concerns about Reye syndrome due to the subsalicylate component.
Δ If bismuth-based quadruple therapy was used initially, options for rescue therapy include an alternative bismuth-based quadruple therapy (eg, with high-dose PPI and amoxicillin) or a levofloxacin based triple regimen.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟